Angion Biomedica (ANGN) director Adams received 4,100 Stock Option (right to buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Julian Adams (director at Angion Biomedica Corp., ANGN) reported that they received 4,100 Stock Option (right to buy) on Dec 28, 2023.
- Reporting person
- Adams Julian
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 28, 2023 | Grant or award (A) | Stock Option (right to buy)On 4,100 Common Stock1 | +4,100 | - | - | 4,100 direct |
Holdings before and after
- Stock Option (right to buy): 0 to 4,100 direct
Footnotes from the filing
- 1. The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Adams report in this ANGN Form 4?
Julian Adams (director at Angion Biomedica Corp., ANGN) reported that they received 4,100 Stock Option (right to buy) on Dec 28, 2023.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for ANGN
Earlier insider filings at ANGN
- Dec 29, 2023SEC Form 4 filed by Venkatesan Jay
- Dec 29, 2023SEC Form 4 filed by Ashe Carol Gail
- Dec 29, 2023SEC Form 4 filed by Ruffolo Robert R
- Dec 26, 2023Chudnovsky Yekaterina bought $7,047,530 worth of shares (1,213,000 units at $5.81) (SEC Form 4)
- Jun 5, 2023SEC Form 4 filed by Piekos Brian
Keep researching ANGN
- ANGN insider tradesEvery buy and sale reported by Angion Biomedica Corp. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
Quantisnow market dataNASDAQ
ANGN
Angion Biomedica Corp.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2021
Get push alerts for ANGN
Full ANGN profile on Quantisnow Follow ANGN and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time